Related references
Note: Only part of the references are listed.Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
Annemieke Cats et al.
LANCET ONCOLOGY (2018)
Predictors of Positive Margins After Definitive Resection for Gastric Adenocarcinoma and Impact of Adjuvant Therapies
Ryan M. Rhome et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial
David Cunningham et al.
LANCET ONCOLOGY (2017)
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
Derek Alderson et al.
LANCET ONCOLOGY (2017)
Treatment of Gastric and Gastroesophageal Cancers-DoWe Really Need Anthracyclines?
Noman Ashraf et al.
JAMA ONCOLOGY (2017)
Chemotherapy for advanced gastric cancer
Anna Dorothea Wagner et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.
Salah-Eddin Al-Batran et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice
Thomas W. Rice et al.
ANNALS OF CARDIOTHORACIC SURGERY (2017)
Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial
N. Fazio et al.
ANNALS OF ONCOLOGY (2016)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. C. Smyth et al.
ANNALS OF ONCOLOGY (2016)
A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: first results from the CRITICS study
M. Verheij et al.
ANNALS OF ONCOLOGY (2016)
Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis
Jun-hua Zhao et al.
BMC CANCER (2016)
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis
Emil ter Veer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis
Meng-long Zhou et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials
Jun Huang et al.
ONCOTARGET (2016)
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis
Emil ter Veer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
An update on the randomized phase III POST trial: S-1 based doublet as an adjuvant chemotherapy for curatively resected stage III gastric cancer
Choong-kun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Prolonged adjuvant capecitabine chemotherapy improved survival of stage IIIA gastric cancer after D2 gastrectomy
Wen Ming Feng et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
Se Hoon Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Rate in Locally Advanced Gastric Cancer A Randomized, Controlled Study
Junxun Ma et al.
MEDICINE (2015)
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
E. Bajetta et al.
ANNALS OF ONCOLOGY (2014)
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Parisa Karimi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
Lee M. Ellis et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial
Akira Tsuburaya et al.
LANCET ONCOLOGY (2014)
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
Sung Hoon Noh et al.
LANCET ONCOLOGY (2014)
Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer
Hai-Bin Cui et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
Y-K Kang et al.
BRITISH JOURNAL OF CANCER (2013)
Platinum-Based Versus Non-Platinum-Based Chemotherapy as First Line Treatment of Inoperable, Advanced Gastric Adenocarcinoma: A Meta-Analysis
Wei-Wei Chen et al.
PLOS ONE (2013)
Cisplatin or Not in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
Fausto Petrelli et al.
PLOS ONE (2013)
Assessing key assumptions of network meta-analysis: a review of methods
Sarah Donegan et al.
RESEARCH SYNTHESIS METHODS (2013)
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Ulrich Ronellenfitsch et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection
Tae Hyun Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery
Changhua Yu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection
Stephen R. Smalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection
Wei-guo Zhu et al.
RADIOTHERAPY AND ONCOLOGY (2012)
What is a multiple treatments meta-analysis?
A. Cipriani et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2012)
Automating network meta-analysis
Gert van Valkenhoef et al.
RESEARCH SYNTHESIS METHODS (2012)
Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma
X. -L. Zhang et al.
EJSO (2011)
Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis
Francesco Montagnani et al.
GASTRIC CANCER (2011)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction
Thomas W. Rice et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection
Hyuk-Chan Kwon et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2010)
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer
Aristotelis Bamias et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Prospective randomized trial of short-term neoadjuvant chemotherapy for advanced gastric cancer
M. Imano et al.
EJSO (2010)
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
Xavier Paoletti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
Christoph Schuhmacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Adjuvant Chemotherapy with Etoposide, Adriamycin and Cisplatin Compared with Surgery Alone in the Treatment of Gastric Cancer: A Phase III Randomized, Multicenter, Clinical Trial
J. Kulig et al.
ONCOLOGY (2010)
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin:: A study of the arbeitsgemeinschaft internistische onkologie
Salah-Eddin Al-Batran et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant chemotherapy in completely resected gastric cancer: A Randomized phase III trial conducted by GOIRC
Francesco Di Costanzo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer
T. Nakajima et al.
BRITISH JOURNAL OF SURGERY (2007)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
Shinichi Sakuramoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
F. De Vita et al.
ANNALS OF ONCOLOGY (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial
Stefano Cascinu et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer
AAK Tentes et al.
LANGENBECKS ARCHIVES OF SURGERY (2006)
Apoptosis induced by preoperative oral 5′-DFUR administration in gastric adenocarcinorna and its mechanism of action
Wen-He Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma - A Randomized phase III trial
Maria Di Bartolomeo et al.
ONCOLOGY (2006)
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer:: 7-year results of the FFCD randomized phase III trial (8801)
O Bouché et al.
ANNALS OF ONCOLOGY (2005)
Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer
J Chipponi et al.
AMERICAN JOURNAL OF SURGERY (2004)
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
HH Hartgrink et al.
EJSO (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Combination of direct and indirect evidence in mixed treatment comparisons
G Lu et al.
STATISTICS IN MEDICINE (2004)
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group
E Bajetta et al.
ANNALS OF ONCOLOGY (2002)
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer
HM Chang et al.
ANNALS OF ONCOLOGY (2002)
Randomized trial of adjuvant chemotherapy versus central after curative resection for gastric cancer: 5-year follow-up
B Neri et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
